Fonte: Nature Communications. Unidade: FCF
Assuntos: ANÁLISE MORFOLÓGICA, CÉLULAS, ESCLEROSE MÚLTIPLA
ABNT
CHAVES, Beatriz et al. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. Nature Communications, v. 16, p. 1-15 art. 5533, 2025Tradução . . Disponível em: https://dx.doi.org/10.1038/s41467-025-60224-3. Acesso em: 25 nov. 2025.APA
Chaves, B., Silva, J. C. S. e, Nakaya, H. T. I., Juglard, N. S., Bucciarelli, F., Prunier, G., et al. (2025). In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. Nature Communications, 16, 1-15 art. 5533. doi:10.1038/s41467-025-60224-3NLM
Chaves B, Silva JCS e, Nakaya HTI, Juglard NS, Bucciarelli F, Prunier G, Almeida MV, Lacouture C, Kari S, Astier AL, Medeiros MA, Silva JHM, Liblau R, Almeida VC de, Dupré L. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis [Internet]. Nature Communications. 2025 ; 16 1-15 art. 5533.[citado 2025 nov. 25 ] Available from: https://dx.doi.org/10.1038/s41467-025-60224-3Vancouver
Chaves B, Silva JCS e, Nakaya HTI, Juglard NS, Bucciarelli F, Prunier G, Almeida MV, Lacouture C, Kari S, Astier AL, Medeiros MA, Silva JHM, Liblau R, Almeida VC de, Dupré L. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis [Internet]. Nature Communications. 2025 ; 16 1-15 art. 5533.[citado 2025 nov. 25 ] Available from: https://dx.doi.org/10.1038/s41467-025-60224-3
